Forge Biologics, a Columbus, Ohio-based gene therapy-focused contract development and manufacturing organization, closed a $120m Series B financing.
The round was led by RA Capital Management with participation from Perceptive Advisors and related affiliates, Surveyor Capital (a Citadel company), Octagon Capital, and Marshall Wace and existing investors Perceptive Xontogeny Venture Fund and Drive Capital. In connection with the financing, Matthew Hammond, Ph.D., of RA Capital, and Fred Callori of the Perceptive Xontogeny Venture Fund will join Forge’s Board of Directors.
The company intends to use the funds to accelerate the expansion of its AAV manufacturing CDMO capabilities with cGMP production capacity, as well as operate its subsidiaries that are advancing novel adeno-associated virus (AAV) gene therapy programs.
Chardan Acts as Exclusive Placement Agent in Forge Biologics $120 Million Series B Financing
Funds raised to accelerate expansion of AAV manufacturing CDMO capabilities and advance novel gene therapy pipeline
News provided by
Share this article
Share this article
NEW YORK, April 29, 2021 /PRNewswire/ Chardan, a global investment bank, today announced that it acted as exclusive placement agent in the successful closing of $120 million Series B financing of Forge Biologics, a gene therapy-focused contract development and manufacturing organization. We are delighted to support the outstanding team of Forge in the goal of raising capital to further accelerate the expansion of their AAV manufacturing CDMO capabilities, while advancing novel AAV gene therapy programs to provide broader access to life-saving therapies, said Murat Omur, Chardan s Head of Healthcare Investment Banking.
Forge Biologics to Present at 2021 Virtual Cell & Gene Meeting on the Mediterranean
News provided by
Share this article
Share this article
COLUMBUS, Ohio, April 6, 2021 /PRNewswire/ Forge Biologics, a cGMP manufacturing and development company, announced today that Timothy J. Miller, Ph.D., Chief Executive Officer, President, and Co-Founder will present at the annual Cell & Gene Meeting on the Mediterranean, which will be held virtually April 6-9, 2021.
Dr. Timothy J. Miller, Ph.D. will be presenting at Meeting on the Med on April 6-9th, 2021. View the full presentation at www.meetingonthemed.com.
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mediterranean is a four-day virtual conference featuring more than 80 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and br
3 Clinton Countians indicted by Highland Co. grand jury
Cox
Dettwiler
HILLSBORO Two Sabina men are facing separate indictments on charges of grand theft of a motor vehicle and tampering with identification numbers to conceal the identity of a vehicle. The indictments were returned Tuesday by a Highland County grand jury.
Dustin R. Cox, 40, Sabina, was indicted on grand theft of a motor vehicle, a fourth-degree felony; and tampering with identification numbers to conceal identity of a vehicle or part, a fifth-degree felony.
The indictment stems from incidents that are alleged to have occurred on Jan. 13-14, of this year involving a 2000 Chevrolet Blazer.